Faecal Diagnostic Biomarkers for Colorectal Cancer
Background: Colorectal cancer (CRC) is a major cause of cancer-related death worldwide. Cancer progression, including invasion and metastasis, is a major cause of death among CRC patients. Current methods for CRC screening commonly consist of a combination of faecal immunochemical test (FIT) for sto...
Guardado en:
Autores principales: | Andrea Cruz, Carla M. Carvalho, Alexandra Cunha, Anais Crespo, Águeda Iglesias, Laura García-Nimo, Paulo P. Freitas, Joaquín Cubiella |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1a4b2170cee495791fe9393265f9ea5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
por: Karen N. Barnett, et al.
Publicado: (2021) -
Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma
por: Zhu Y, et al.
Publicado: (2021) -
Leveraging Existing 16S rRNA Gene Surveys To Identify Reproducible Biomarkers in Individuals with Colorectal Tumors
por: Marc A. Sze, et al.
Publicado: (2018) -
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis
por: Minsuk Kim, et al.
Publicado: (2020) -
How to improve the adenoma detection rate in colorectal cancer screening? Clinical factors and technological advancements
por: Maciej Matyja, et al.
Publicado: (2019)